How to Detect Isolated PEX10-Related Cerebellar Ataxia?
Nava E, Hartmann B, Boxheimer L, Capone Mori A, Nuoffer J-M, Sargsyan Y, Thoms S, Rosewich H, Boltshauser E (2022)
Neuropediatrics.
Zeitschriftenaufsatz
| E-Veröff. vor dem Druck | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Nava, Esmeralda;
Hartmann, Britta;
Boxheimer, Larissa;
Capone Mori, Andrea;
Nuoffer, Jean-Marc;
Sargsyan, Yelena;
Thoms, SvenUniBi;
Rosewich, Hendrik;
Boltshauser, Eugen
Einrichtung
Abstract / Bemerkung
A 4-year-old boy presented with subacute onset of cerebellar ataxia. Neuroimaging revealed cerebellar atrophy. Metabolic screening tests aiming to detect potentially treatable ataxias showed an increased value (fourfold upper limit of normal) for phytanic acid and elevated very-long-chain fatty acid (VLCFA) ratios (C24:0/C22:0 and C26:0/C22:0), while absolute concentrations of VLCFA were normal. Genetic analysis identified biallelic variants in PEX10. Immunohistochemistry confirmed pathogenicity in the patients' cultured fibroblasts demonstrating peroxisomal mosaicism with a general catalase import deficiency as well as conspicuous peroxisome morphology as an expression of impaired peroxisomal function. We describe for the first time an elongated peroxisome morphology in a patient with PEX10-related cerebellar ataxia.A literature search yielded 14 similar patients from nine families with PEX10-related cerebellar ataxia, most of them presenting their first symptoms between 3 and 8 years of age. In 11/14 patients, the first and main symptom was cerebellar ataxia; in three patients, it was sensorineural hearing impairment. Finally, all 14 patients developed ataxia. Polyneuropathy (9/14) and cognitive impairment (9/14) were common associated findings. In 12/13 patients brain MRI showed cerebellar atrophy. Phytanic acid was elevated in 8/12 patients, while absolute concentrations of VLCFA levels were in normal limits in several patients. VLCFA ratios (C24:0/C22:0 and/or C26:0/C22:0), though, were elevated in 11/11 cases. We suggest including measurement of phytanic acid and VLCFA ratios in metabolic screening tests in unexplained autosomal recessive ataxias with cerebellar atrophy, especially when there is an early onset and symptoms are mild. Thieme. All rights reserved.
Erscheinungsjahr
2022
Zeitschriftentitel
Neuropediatrics
eISSN
1439-1899
Page URI
https://pub.uni-bielefeld.de/record/2960854
Zitieren
Nava E, Hartmann B, Boxheimer L, et al. How to Detect Isolated PEX10-Related Cerebellar Ataxia? Neuropediatrics. 2022.
Nava, E., Hartmann, B., Boxheimer, L., Capone Mori, A., Nuoffer, J. - M., Sargsyan, Y., Thoms, S., et al. (2022). How to Detect Isolated PEX10-Related Cerebellar Ataxia? Neuropediatrics. https://doi.org/10.1055/s-0041-1741383
Nava, Esmeralda, Hartmann, Britta, Boxheimer, Larissa, Capone Mori, Andrea, Nuoffer, Jean-Marc, Sargsyan, Yelena, Thoms, Sven, Rosewich, Hendrik, and Boltshauser, Eugen. 2022. “How to Detect Isolated PEX10-Related Cerebellar Ataxia?”. Neuropediatrics.
Nava, E., Hartmann, B., Boxheimer, L., Capone Mori, A., Nuoffer, J. - M., Sargsyan, Y., Thoms, S., Rosewich, H., and Boltshauser, E. (2022). How to Detect Isolated PEX10-Related Cerebellar Ataxia? Neuropediatrics.
Nava, E., et al., 2022. How to Detect Isolated PEX10-Related Cerebellar Ataxia? Neuropediatrics.
E. Nava, et al., “How to Detect Isolated PEX10-Related Cerebellar Ataxia?”, Neuropediatrics, 2022.
Nava, E., Hartmann, B., Boxheimer, L., Capone Mori, A., Nuoffer, J.-M., Sargsyan, Y., Thoms, S., Rosewich, H., Boltshauser, E.: How to Detect Isolated PEX10-Related Cerebellar Ataxia? Neuropediatrics. (2022).
Nava, Esmeralda, Hartmann, Britta, Boxheimer, Larissa, Capone Mori, Andrea, Nuoffer, Jean-Marc, Sargsyan, Yelena, Thoms, Sven, Rosewich, Hendrik, and Boltshauser, Eugen. “How to Detect Isolated PEX10-Related Cerebellar Ataxia?”. Neuropediatrics (2022).
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 35038753
PubMed | Europe PMC
Suchen in